Table 3.

Direct costs (€/patient/month)

Cost category	Disease condition
	Hepatitis	Cirrhosis	HCC	OLT
	Mean (minimum–maximum)	Mean (minimum–maximum)	Mean (minimum–maximum)	Mean (minimum–maximum)
Medical costs
Conventional, antiviral drug treatment	167.1 (0–1921.9)	47.9 (0–597.2)	62.8 (0–508.8)	150.6 (0–1830.0)
Conventional, other (non-antiviral) drug treatment	4.0 (0–325.5)	99.1 (0–1543.5)	75.1 (0–1038.6)	917.9 (25.2–6052.0)
Unconventional treatment	10.2 (0–533.3)	22.5 (0–400.0)	17.3 (0–207.7)	16.8 (0–300.0)
Hospitalisations	49.0 (0–3075.0)	259.3 (0–4612.5)	999.8 (0–2590.3)	1483.9 (38.0–13 370.3)
Outpatient visits/examinations	16.9 (0–163.2)	25.5 (0–105.0)	23.6 (0–141.3)	8.2 (0–38.7)
Non-medical costs
Formal caregiving	2.7 (0–500.0)	9.2 (0–500.0)	9.3 (0–166.7)	17.8 (0–300.0)
Travelling and accommodation	12.8 (0–500.0)	38.3 (0–500.0)	41.2 (0–375.0)	79.5 (0–1166.7)
Total direct costs	262.8 (3.7–3166.8)	501.7 (7.9–4693.6)	1229.2 (11.4–3916.0)	2674.7 (155.7–15 669.7)

HCC, hepatocellular carcinoma; OLT, orthotopic liver transplantation.